25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Clariane SE
Buy, Hold or Sell?

Let's analyze Clariane together

I guess you are interested in Clariane SE. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Clariane SE. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Clariane SE

I send you an email if I find something interesting about Clariane SE.

1. Quick Overview

1.1. Quick analysis of Clariane (30 sec.)










1.2. What can you expect buying and holding a share of Clariane? (30 sec.)

How much money do you get?

How much money do you get?
€0.28
When do you have the money?
1 year
How often do you get paid?
72.5%

What is your share worth?

Current worth
€10.84
Expected worth in 1 year
€10.81
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
€0.23
Return On Investment
12.2%

For what price can you sell your share?

Current Price per Share
€1.90
Expected price per share
€1.491 - €2.37
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Clariane (5 min.)




Live pricePrice per Share (EOD)
€1.90

2.2. Growth of Clariane (5 min.)




Is Clariane growing?

Current yearPrevious yearGrowGrow %
How rich?$4b$4b$30.4m0.7%

How much money is Clariane making?

Current yearPrevious yearGrowGrow %
Making money-$51.9m$6.4m-$58.3m-112.4%
Net Profit Margin-2.8%0.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Clariane (5 min.)




2.4. Comparing to competitors in the Medical Care Facilities industry (5 min.)




  Industry Rankings (Medical Care Facilities)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Clariane?

Welcome investor! Clariane's management wants to use your money to grow the business. In return you get a share of Clariane.

First you should know what it really means to hold a share of Clariane. And how you can make/lose money.

Speculation

The Price per Share of Clariane is €1.896. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Clariane.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Clariane, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €10.84. Based on the TTM, the Book Value Change Per Share is €-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is €0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.07 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Clariane.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.08-4.1%-0.15-7.7%0.021.0%0.021.1%0.062.9%
Usd Book Value Change Per Share0.00-0.1%-0.01-0.5%0.073.8%0.2010.7%0.157.7%
Usd Dividend Per Share0.052.8%0.073.7%0.073.7%0.052.4%0.031.8%
Usd Total Gains Per Share0.052.8%0.063.2%0.147.6%0.2513.1%0.189.5%
Usd Price Per Share1.94-3.01-9.00-21.16-26.51-
Price to Earnings Ratio-6.26--6.89-209.36-136.94-143.19-
Price-to-Total Gains Ratio36.88-17.18-140.86-689.58--293,717.14-
Price to Book Ratio0.17-0.26-0.79-2.24-3.62-
Price-to-Total Gains Ratio36.88-17.18-140.86-689.58--293,717.14-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.9989528
Number of shares500
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.070.05
Usd Book Value Change Per Share-0.010.20
Usd Total Gains Per Share0.060.25
Gains per Quarter (500 shares)30.51123.96
Gains per Year (500 shares)122.04495.84
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1140-1811290405486
2280-35234181811982
3419-5335627112161478
4559-7147836216211974
5699-8960045220272470
6839-10672254324322966
7978-12484463328383462
81118-14296672432433958
91258-160108881436484454
101398-177121090540544950

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%8.04.00.066.7%16.04.00.080.0%36.04.00.090.0%42.04.00.091.3%
Book Value Change Per Share1.02.01.025.0%5.02.05.041.7%9.03.08.045.0%17.07.016.042.5%20.07.019.043.5%
Dividend per Share3.00.01.075.0%11.00.01.091.7%19.00.01.095.0%29.00.011.072.5%31.00.015.067.4%
Total Gains per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%32.04.04.080.0%36.04.06.078.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Clariane SE compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.008+743%0.069-101%0.192-101%0.139-101%
Book Value Per Share--10.84210.956-1%10.8750%9.892+10%8.010+35%
Current Ratio--0.5910.664-11%0.589+0%0.693-15%0.682-13%
Debt To Asset Ratio--0.7360.7380%0.7360%0.745-1%0.710+4%
Debt To Equity Ratio--3.0853.111-1%3.071+0%3.135-2%2.637+17%
Dividend Per Share--0.0510.066-23%0.067-24%0.043+19%0.032+59%
Eps---0.073-0.138+89%0.017-529%0.020-463%0.052-241%
Free Cash Flow Per Share--0.3910.409-4%0.103+278%0.230+70%0.179+118%
Free Cash Flow To Equity Per Share---0.4840.214-326%-0.329-32%0.327-248%0.249-294%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap674411022.336+3%654491709.4401015351404.672-36%3037695216.640-78%7140147069.464-91%8942855557.613-93%
Net Profit Margin---0.020-0.028+40%0.004-582%0.006-444%0.022-192%
Operating Margin--0.0510.064-20%0.064-20%0.069-26%0.078-34%
Operating Ratio--0.9540.9550%0.949+1%0.933+2%0.927+3%
Pb Ratio0.175+3%0.1700.259-35%0.785-78%2.242-92%3.620-95%
Pe Ratio-6.453-3%-6.262-6.887+10%209.361-103%136.944-105%143.187-104%
Price Per Share1.896+3%1.8402.855-36%8.540-78%20.073-91%25.141-93%
Price To Free Cash Flow Ratio1.214+3%1.1781.515-22%86.324-99%35.118-97%61.663-98%
Price To Total Gains Ratio38.001+3%36.87917.176+115%140.857-74%689.580-95%-293717.144+796535%
Quick Ratio--0.3630.409-11%0.412-12%0.519-30%0.495-27%
Return On Assets---0.002-0.003+83%0.000-528%0.001-367%0.003-171%
Return On Equity---0.007-0.014+84%0.002-534%0.003-370%0.008-192%
Total Gains Per Share--0.0500.058-14%0.136-63%0.235-79%0.171-71%
Usd Book Value--4066060823.5004108761291.375-1%4078293866.4000%3709499673.738+10%3003758343.879+35%
Usd Book Value Change Per Share---0.001-0.009+743%0.072-101%0.203-101%0.146-101%
Usd Book Value Per Share--11.43111.551-1%11.4650%10.429+10%8.445+35%
Usd Dividend Per Share--0.0540.070-23%0.071-24%0.045+19%0.034+59%
Usd Eps---0.077-0.146+89%0.018-529%0.021-463%0.055-241%
Usd Free Cash Flow--146444905.750115000803.613+27%38754486.550+278%81859726.553+79%65568801.561+123%
Usd Free Cash Flow Per Share--0.4120.431-4%0.109+278%0.242+70%0.189+118%
Usd Free Cash Flow To Equity Per Share---0.5100.226-326%-0.347-32%0.345-248%0.263-294%
Usd Market Cap711031540.849+3%690030609.2631070484985.946-36%3202642066.904-78%7527857055.336-91%9428452614.391-93%
Usd Price Per Share1.999+3%1.9403.009-36%9.004-78%21.163-91%26.507-93%
Usd Profit---27547277.550-51927437.900+89%6428462.463-529%7597997.453-463%19584584.549-241%
Usd Revenue--1385413458.0001704184094.113-19%1887852642.813-27%1678780445.680-17%1259568888.955+10%
Usd Total Gains Per Share--0.0530.061-14%0.143-63%0.248-79%0.180-71%
 EOD+5 -3MRQTTM+16 -19YOY+9 -265Y+14 -2110Y+14 -21

3.3 Fundamental Score

Let's check the fundamental score of Clariane SE based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.453
Price to Book Ratio (EOD)Between0-10.175
Net Profit Margin (MRQ)Greater than0-0.020
Operating Margin (MRQ)Greater than00.051
Quick Ratio (MRQ)Greater than10.363
Current Ratio (MRQ)Greater than10.591
Debt to Asset Ratio (MRQ)Less than10.736
Debt to Equity Ratio (MRQ)Less than13.085
Return on Equity (MRQ)Greater than0.15-0.007
Return on Assets (MRQ)Greater than0.05-0.002
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Clariane SE based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.407
Ma 20Greater thanMa 501.928
Ma 50Greater thanMa 1001.784
Ma 100Greater thanMa 2001.824
OpenGreater thanClose1.920
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Clariane SE

Clariane SE provides a range of medical and non-medical care and support services for the elderly and people with short or longer-term health issues. The company operates long-term care nursing homes, specialized clinics, and assisted living and shared housing facilities for seniors, as well as offers home care, support, and hospitalization services. It operates approximately health care facilities and networks in France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom. The company was formerly known as Korian and changed its name to Clariane SE in June 2023. Clariane SE was founded in 2001 and is headquartered in Paris, France.

Fundamental data was last updated by Penke on 2024-11-13 09:24:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Clariane earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Clariane to the Medical Care Facilities industry mean.
  • A Net Profit Margin of -2.0% means that €-0.02 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Clariane SE:

  • The MRQ is -2.0%. The company is making a loss. -1
  • The TTM is -2.8%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-2.0%TTM-2.8%+0.8%
TTM-2.8%YOY0.4%-3.2%
TTM-2.8%5Y0.6%-3.4%
5Y0.6%10Y2.2%-1.6%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.0%4.0%-6.0%
TTM-2.8%3.2%-6.0%
YOY0.4%2.4%-2.0%
5Y0.6%3.2%-2.6%
10Y2.2%3.3%-1.1%
4.3.1.2. Return on Assets

Shows how efficient Clariane is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Clariane to the Medical Care Facilities industry mean.
  • -0.2% Return on Assets means that Clariane generated €0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Clariane SE:

  • The MRQ is -0.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.2%TTM-0.3%+0.1%
TTM-0.3%YOY0.0%-0.4%
TTM-0.3%5Y0.1%-0.4%
5Y0.1%10Y0.3%-0.2%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.2%1.1%-1.3%
TTM-0.3%1.2%-1.5%
YOY0.0%0.5%-0.5%
5Y0.1%1.0%-0.9%
10Y0.3%1.0%-0.7%
4.3.1.3. Return on Equity

Shows how efficient Clariane is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Clariane to the Medical Care Facilities industry mean.
  • -0.7% Return on Equity means Clariane generated €-0.01 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Clariane SE:

  • The MRQ is -0.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -1.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.7%TTM-1.4%+0.6%
TTM-1.4%YOY0.2%-1.6%
TTM-1.4%5Y0.3%-1.7%
5Y0.3%10Y0.8%-0.5%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.7%2.8%-3.5%
TTM-1.4%2.9%-4.3%
YOY0.2%1.8%-1.6%
5Y0.3%2.3%-2.0%
10Y0.8%2.6%-1.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Clariane SE.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Clariane is operating .

  • Measures how much profit Clariane makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Clariane to the Medical Care Facilities industry mean.
  • An Operating Margin of 5.1% means the company generated €0.05  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Clariane SE:

  • The MRQ is 5.1%. The company is operating less efficient.
  • The TTM is 6.4%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ5.1%TTM6.4%-1.3%
TTM6.4%YOY6.4%+0.0%
TTM6.4%5Y6.9%-0.5%
5Y6.9%10Y7.8%-0.9%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ5.1%6.7%-1.6%
TTM6.4%6.8%-0.4%
YOY6.4%7.8%-1.4%
5Y6.9%7.5%-0.6%
10Y7.8%8.1%-0.3%
4.3.2.2. Operating Ratio

Measures how efficient Clariane is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • An Operation Ratio of 0.95 means that the operating costs are €0.95 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Clariane SE:

  • The MRQ is 0.954. The company is less efficient in keeping operating costs low.
  • The TTM is 0.955. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.954TTM0.955-0.001
TTM0.955YOY0.949+0.006
TTM0.9555Y0.933+0.022
5Y0.93310Y0.927+0.006
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9541.034-0.080
TTM0.9551.041-0.086
YOY0.9490.994-0.045
5Y0.9330.989-0.056
10Y0.9270.977-0.050
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Clariane SE.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Clariane is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A Current Ratio of 0.59 means the company has €0.59 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Clariane SE:

  • The MRQ is 0.591. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.664. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.591TTM0.664-0.073
TTM0.664YOY0.589+0.076
TTM0.6645Y0.693-0.029
5Y0.69310Y0.682+0.011
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5911.235-0.644
TTM0.6641.261-0.597
YOY0.5891.312-0.723
5Y0.6931.397-0.704
10Y0.6821.424-0.742
4.4.3.2. Quick Ratio

Measures if Clariane is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Clariane to the Medical Care Facilities industry mean.
  • A Quick Ratio of 0.36 means the company can pay off €0.36 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Clariane SE:

  • The MRQ is 0.363. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.409. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.363TTM0.409-0.046
TTM0.409YOY0.412-0.002
TTM0.4095Y0.519-0.110
5Y0.51910Y0.495+0.024
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3630.724-0.361
TTM0.4090.807-0.398
YOY0.4121.027-0.615
5Y0.5191.098-0.579
10Y0.4951.165-0.670
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Clariane SE.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Clariane assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Clariane to Medical Care Facilities industry mean.
  • A Debt to Asset Ratio of 0.74 means that Clariane assets are financed with 73.6% credit (debt) and the remaining percentage (100% - 73.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Clariane SE:

  • The MRQ is 0.736. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.738. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.736TTM0.738-0.002
TTM0.738YOY0.736+0.002
TTM0.7385Y0.745-0.007
5Y0.74510Y0.710+0.035
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7360.522+0.214
TTM0.7380.520+0.218
YOY0.7360.521+0.215
5Y0.7450.539+0.206
10Y0.7100.528+0.182
4.5.4.2. Debt to Equity Ratio

Measures if Clariane is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Clariane to the Medical Care Facilities industry mean.
  • A Debt to Equity ratio of 308.5% means that company has €3.09 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Clariane SE:

  • The MRQ is 3.085. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.111. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.085TTM3.111-0.026
TTM3.111YOY3.071+0.040
TTM3.1115Y3.135-0.024
5Y3.13510Y2.637+0.498
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0850.993+2.092
TTM3.1111.007+2.104
YOY3.0711.006+2.065
5Y3.1351.120+2.015
10Y2.6371.226+1.411
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Clariane generates.

  • Above 15 is considered overpriced but always compare Clariane to the Medical Care Facilities industry mean.
  • A PE ratio of -6.26 means the investor is paying €-6.26 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Clariane SE:

  • The EOD is -6.453. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.262. Based on the earnings, the company is expensive. -2
  • The TTM is -6.887. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.453MRQ-6.262-0.191
MRQ-6.262TTM-6.887+0.625
TTM-6.887YOY209.361-216.248
TTM-6.8875Y136.944-143.831
5Y136.94410Y143.187-6.243
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD-6.45314.154-20.607
MRQ-6.26214.072-20.334
TTM-6.88713.352-20.239
YOY209.36112.019+197.342
5Y136.94416.469+120.475
10Y143.18721.068+122.119
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Clariane SE:

  • The EOD is 1.214. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 1.178. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 1.515. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.214MRQ1.178+0.036
MRQ1.178TTM1.515-0.337
TTM1.515YOY86.324-84.809
TTM1.5155Y35.118-33.603
5Y35.11810Y61.663-26.545
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD1.2148.846-7.632
MRQ1.1788.896-7.718
TTM1.5156.758-5.243
YOY86.3247.804+78.520
5Y35.1186.226+28.892
10Y61.6636.276+55.387
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Clariane is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A PB ratio of 0.17 means the investor is paying €0.17 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Clariane SE:

  • The EOD is 0.175. Based on the equity, the company is cheap. +2
  • The MRQ is 0.170. Based on the equity, the company is cheap. +2
  • The TTM is 0.259. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.175MRQ0.170+0.005
MRQ0.170TTM0.259-0.090
TTM0.259YOY0.785-0.526
TTM0.2595Y2.242-1.982
5Y2.24210Y3.620-1.379
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD0.1751.763-1.588
MRQ0.1701.906-1.736
TTM0.2591.977-1.718
YOY0.7852.142-1.357
5Y2.2422.404-0.162
10Y3.6202.777+0.843
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Other Stockholders Equity  253,816952,4341,206,25001,206,25089,7501,296,000-1,466,936-170,936



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. All numbers in thousands.

Summary
Total Assets14,614,526
Total Liabilities10,757,881
Total Stockholder Equity3,486,992
 As reported
Total Liabilities 10,757,881
Total Stockholder Equity+ 3,486,992
Total Assets = 14,614,526

Assets

Total Assets14,614,526
Total Current Assets1,861,863
Long-term Assets12,752,663
Total Current Assets
Cash And Cash Equivalents 515,195
Short-term Investments 2,945
Net Receivables 618,907
Inventory 25,493
Other Current Assets 630,931
Total Current Assets  (as reported)1,861,863
Total Current Assets  (calculated)1,793,471
+/- 68,392
Long-term Assets
Property Plant Equipment 6,872,656
Goodwill 3,252,928
Intangible Assets 2,345,248
Long-term Assets Other 1,452
Long-term Assets  (as reported)12,752,663
Long-term Assets  (calculated)12,472,284
+/- 280,379

Liabilities & Shareholders' Equity

Total Current Liabilities3,151,119
Long-term Liabilities7,606,762
Total Stockholder Equity3,486,992
Total Current Liabilities
Short-term Debt 1,129,766
Accounts payable 562,831
Other Current Liabilities 1,357,139
Total Current Liabilities  (as reported)3,151,119
Total Current Liabilities  (calculated)3,049,736
+/- 101,383
Long-term Liabilities
Long-term Liabilities  (as reported)7,606,762
Long-term Liabilities  (calculated)0
+/- 7,606,762
Total Stockholder Equity
Common Stock1,424
Retained Earnings 1,466,832
Accumulated Other Comprehensive Income 2,189,672
Other Stockholders Equity -170,936
Total Stockholder Equity (as reported)3,486,992
Total Stockholder Equity (calculated)3,486,992
+/-0
Other
Cash and Short Term Investments 522,448
Common Stock Shares Outstanding 110,238
Current Deferred Revenue101,383
Liabilities and Stockholders Equity 14,614,526
Net Debt 7,853,868
Net Working Capital -1,289,256
Short Long Term Debt Total 8,369,063



6.3. Balance Sheets Structured

All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-06-302011-12-312011-06-302010-12-312010-06-302009-12-31
> Total Assets 
1,821,769
1,857,318
1,894,906
1,956,930
2,089,002
2,125,760
2,231,886
2,347,149
2,347,149
2,316,755
2,316,755
4,647,779
4,647,779
5,254,983
5,254,983
5,313,041
5,313,041
5,765,027
5,765,027
6,292,336
6,292,336
6,494,178
6,494,178
6,686,880
6,686,880
7,114,922
7,114,922
7,278,502
7,278,502
7,623,465
7,623,465
10,720,127
10,720,127
10,938,240
10,938,240
11,884,417
11,884,417
13,197,328
13,197,328
13,737,707
13,737,707
14,308,073
14,308,073
14,334,571
14,334,571
14,573,562
14,573,562
14,766,229
14,766,229
15,180,911
15,180,911
14,615,000
14,614,526
14,614,52614,615,00015,180,91115,180,91114,766,22914,766,22914,573,56214,573,56214,334,57114,334,57114,308,07314,308,07313,737,70713,737,70713,197,32813,197,32811,884,41711,884,41710,938,24010,938,24010,720,12710,720,1277,623,4657,623,4657,278,5027,278,5027,114,9227,114,9226,686,8806,686,8806,494,1786,494,1786,292,3366,292,3365,765,0275,765,0275,313,0415,313,0415,254,9835,254,9834,647,7794,647,7792,316,7552,316,7552,347,1492,347,1492,231,8862,125,7602,089,0021,956,9301,894,9061,857,3181,821,769
   > Total Current Assets 
274,189
269,833
243,057
232,136
258,223
248,444
457,378
325,484
325,484
276,477
276,475
522,189
522,189
636,585
636,584
650,546
650,546
881,093
881,094
580,392
580,392
715,785
715,786
837,400
837,400
929,439
929,437
929,452
929,452
998,964
998,965
895,147
895,147
903,232
903,232
1,274,503
1,274,502
1,882,711
1,882,714
2,082,513
2,082,514
2,205,351
2,205,351
2,023,874
2,023,873
1,917,749
1,917,749
1,776,133
1,776,133
2,498,498
2,498,497
1,861,000
1,861,863
1,861,8631,861,0002,498,4972,498,4981,776,1331,776,1331,917,7491,917,7492,023,8732,023,8742,205,3512,205,3512,082,5142,082,5131,882,7141,882,7111,274,5021,274,503903,232903,232895,147895,147998,965998,964929,452929,452929,437929,439837,400837,400715,786715,785580,392580,392881,094881,093650,546650,546636,584636,585522,189522,189276,475276,477325,484325,484457,378248,444258,223232,136243,057269,833274,189
       Cash And Cash Equivalents 
104,403
70,128
50,723
30,769
41,158
26,737
162,723
49,089
49,089
50,847
50,846
92,557
92,557
235,495
235,495
212,010
212,010
518,833
518,833
155,804
155,804
309,875
309,875
408,270
408,270
510,589
510,589
458,895
458,895
550,361
550,361
366,895
366,895
344,786
344,786
644,549
644,549
1,159,109
1,159,109
1,000,952
1,000,952
1,214,564
1,214,564
884,397
884,397
733,710
733,710
375,007
375,007
677,879
677,879
515,000
515,195
515,195515,000677,879677,879375,007375,007733,710733,710884,397884,3971,214,5641,214,5641,000,9521,000,9521,159,1091,159,109644,549644,549344,786344,786366,895366,895550,361550,361458,895458,895510,589510,589408,270408,270309,875309,875155,804155,804518,833518,833212,010212,010235,495235,49592,55792,55750,84650,84749,08949,089162,72326,73741,15830,76950,72370,128104,403
       Short-term Investments 
697
309
1,487
1,684
8
101
-12,929
0
0
1,217
1,217
0
0
1,245
5
0
0
1,243
4
0
0
1,187
3
2,903
2,903
1,883
1,454
851
851
1,158
27
0
4,464
1,416
23
2,141
34
3,701
81
1,542
28
2,971
1,700
3,936
1,620
2,857
636
2,225
656
1,715
36
12,000
2,945
2,94512,000361,7156562,2256362,8571,6203,9361,7002,971281,542813,701342,141231,4164,4640271,1588518511,4541,8832,9032,90331,1870041,2430051,245001,2171,21700-12,92910181,6841,487309697
       Net Receivables 
166,321
0
0
196,819
0
0
0
88,085
88,085
85,563
85,563
176,359
176,359
142,603
142,603
161,780
161,780
154,228
154,228
169,467
169,467
168,241
168,241
184,561
184,561
191,219
191,219
218,160
218,160
235,611
235,611
252,596
500,162
284,047
465,973
285,300
526,576
315,301
623,515
377,971
774,836
364,674
781,302
406,364
831,787
440,368
792,556
492,563
1,047,349
565,166
1,141,206
619,000
618,907
618,907619,0001,141,206565,1661,047,349492,563792,556440,368831,787406,364781,302364,674774,836377,971623,515315,301526,576285,300465,973284,047500,162252,596235,611235,611218,160218,160191,219191,219184,561184,561168,241168,241169,467169,467154,228154,228161,780161,780142,603142,603176,359176,35985,56385,56388,08588,085000196,81900166,321
       Inventory 
2,767
2,515
2,671
2,863
3,034
3,247
2,993
4,096
4,096
4,096
4,096
7,779
7,779
7,430
7,430
7,851
7,851
8,170
8,170
9,245
9,245
9,707
9,707
10,023
10,023
10,402
10,402
13,617
13,617
17,113
17,113
20,660
20,660
33,909
33,909
36,305
36,305
36,186
36,186
46,213
46,213
28,236
28,236
26,467
26,467
28,623
28,623
29,873
29,873
28,297
28,297
25,000
25,493
25,49325,00028,29728,29729,87329,87328,62328,62326,46726,46728,23628,23646,21346,21336,18636,18636,30536,30533,90933,90920,66020,66017,11317,11313,61713,61710,40210,40210,02310,0239,7079,7079,2459,2458,1708,1707,8517,8517,4307,4307,7797,7794,0964,0964,0964,0962,9933,2473,0342,8632,6712,5152,767
       Other Current Assets 
1
0
0
1
0
0
0
184,214
184,214
134,754
134,754
245,494
245,494
249,812
249,812
268,905
268,905
198,619
198,619
245,876
245,876
226,775
226,775
234,546
234,546
215,346
215,346
238,780
238,780
194,721
194,721
254,996
2,966
239,074
53,945
306,208
64,149
368,414
61,685
655,835
86,837
594,906
96,745
702,710
121,541
712,191
98,477
876,465
138,667
1,225,441
119,645
690,000
630,931
630,931690,000119,6451,225,441138,667876,46598,477712,191121,541702,71096,745594,90686,837655,83561,685368,41464,149306,20853,945239,0742,966254,996194,721194,721238,780238,780215,346215,346234,546234,546226,775226,775245,876245,876198,619198,619268,905268,905249,812249,812245,494245,494134,754134,754184,214184,2140001001
   > Long-term Assets 
1,547,580
1,587,485
1,651,849
1,724,794
1,830,779
1,877,316
1,774,508
2,021,665
2,021,664
2,040,278
2,040,279
4,125,590
4,125,592
4,618,398
4,618,399
4,662,495
4,662,495
4,883,934
4,883,933
5,711,944
5,711,944
5,778,393
5,778,393
5,849,480
5,849,480
6,185,483
6,185,484
6,349,050
6,349,050
6,624,501
6,624,501
9,824,980
9,824,979
10,035,008
10,035,008
10,609,914
10,609,913
11,314,617
11,314,617
11,655,194
11,655,195
12,102,722
12,102,722
12,310,697
12,310,698
12,655,813
12,655,813
12,990,096
12,990,096
12,682,413
12,682,413
12,754,000
12,752,663
12,752,66312,754,00012,682,41312,682,41312,990,09612,990,09612,655,81312,655,81312,310,69812,310,69712,102,72212,102,72211,655,19511,655,19411,314,61711,314,61710,609,91310,609,91410,035,00810,035,0089,824,9799,824,9806,624,5016,624,5016,349,0506,349,0506,185,4846,185,4835,849,4805,849,4805,778,3935,778,3935,711,9445,711,9444,883,9334,883,9344,662,4954,662,4954,618,3994,618,3984,125,5924,125,5902,040,2792,040,2782,021,6642,021,6651,774,5081,877,3161,830,7791,724,7941,651,8491,587,4851,547,580
       Property Plant Equipment 
301,379
326,828
337,017
373,131
404,759
420,124
386,808
533,903
533,903
555,485
555,485
1,037,630
1,037,630
1,165,480
1,165,481
1,179,832
1,179,832
1,295,551
1,295,551
1,611,703
1,611,703
1,670,218
1,670,218
1,712,045
1,712,045
1,943,851
1,943,852
2,037,694
2,037,694
2,292,431
2,292,432
5,336,376
5,336,376
5,472,583
5,472,583
5,802,506
5,802,506
6,102,120
6,102,119
6,209,000
6,209,000
6,547,545
6,547,543
6,713,834
6,713,834
7,004,435
7,004,435
7,037,126
7,037,127
6,796,708
6,796,709
6,873,000
6,872,656
6,872,6566,873,0006,796,7096,796,7087,037,1277,037,1267,004,4357,004,4356,713,8346,713,8346,547,5436,547,5456,209,0006,209,0006,102,1196,102,1205,802,5065,802,5065,472,5835,472,5835,336,3765,336,3762,292,4322,292,4312,037,6942,037,6941,943,8521,943,8511,712,0451,712,0451,670,2181,670,2181,611,7031,611,7031,295,5511,295,5511,179,8321,179,8321,165,4811,165,4801,037,6301,037,630555,485555,485533,903533,903386,808420,124404,759373,131337,017326,828301,379
       Goodwill 
621,659
630,810
643,642
673,708
687,593
699,445
666,795
756,359
756,359
743,204
743,204
2,262,504
2,262,504
1,617,589
1,617,589
1,650,364
1,650,364
1,707,317
1,707,317
2,132,114
2,132,114
2,175,429
2,175,429
2,201,544
2,201,544
2,218,729
2,218,729
2,306,303
2,306,303
2,311,822
2,311,822
2,408,938
2,408,938
2,504,154
2,504,154
2,674,375
2,674,375
2,905,604
2,905,604
3,115,481
3,115,481
3,213,838
3,213,838
3,231,053
3,231,053
3,237,256
3,237,256
3,346,592
3,346,592
3,287,524
3,287,524
3,253,000
3,252,928
3,252,9283,253,0003,287,5243,287,5243,346,5923,346,5923,237,2563,237,2563,231,0533,231,0533,213,8383,213,8383,115,4813,115,4812,905,6042,905,6042,674,3752,674,3752,504,1542,504,1542,408,9382,408,9382,311,8222,311,8222,306,3032,306,3032,218,7292,218,7292,201,5442,201,5442,175,4292,175,4292,132,1142,132,1141,707,3171,707,3171,650,3641,650,3641,617,5891,617,5892,262,5042,262,504743,204743,204756,359756,359666,795699,445687,593673,708643,642630,810621,659
       Intangible Assets 
588,079
589,115
624,436
635,424
684,024
701,579
657,909
660,945
660,945
657,760
657,760
725,587
725,587
1,713,309
1,713,309
1,708,157
1,708,157
1,700,952
1,700,952
1,715,126
1,715,126
1,717,635
1,717,634
1,719,602
1,719,602
1,759,714
1,759,714
1,763,426
1,763,425
1,822,819
1,822,819
1,851,159
1,851,159
1,943,860
1,943,859
1,970,645
1,970,644
2,157,750
2,157,751
2,162,355
2,162,355
2,180,718
2,180,718
2,192,732
2,192,732
2,256,714
2,256,714
2,320,330
2,320,331
2,342,997
2,342,997
2,345,000
2,345,248
2,345,2482,345,0002,342,9972,342,9972,320,3312,320,3302,256,7142,256,7142,192,7322,192,7322,180,7182,180,7182,162,3552,162,3552,157,7512,157,7501,970,6441,970,6451,943,8591,943,8601,851,1591,851,1591,822,8191,822,8191,763,4251,763,4261,759,7141,759,7141,719,6021,719,6021,717,6341,717,6351,715,1261,715,1261,700,9521,700,9521,708,1571,708,1571,713,3091,713,309725,587725,587657,760657,760660,945660,945657,909701,579684,024635,424624,436589,115588,079
       Long-term Assets Other 
697
309
1,487
1,684
15,422
103
1
70,447
-1
70,276
12,270
99,869
1
119,934
30,473
124,142
31,745
178,260
29,373
253,001
31,263
213,819
31,317
216,289
1
240,487
32,922
241,627
1
197,429
27
153,552
-1
76,259
1
156,784
0
79,181
0
96,794
1
98,482
2
113,681
2
86,934
0
121,466
-2
87,412
35
117,000
1,452
1,452117,0003587,412-2121,466086,9342113,681298,482196,794079,1810156,784176,259-1153,55227197,4291241,62732,922240,4871216,28931,317213,81931,263253,00129,373178,26031,745124,14230,473119,934199,86912,27070,276-170,447110315,4221,6841,487309697
> Total Liabilities 
1,121,068
1,173,003
1,176,589
1,246,278
1,366,223
1,416,499
1,499,138
1,609,761
1,609,761
1,548,327
1,548,327
2,767,152
2,767,152
3,352,431
3,352,431
3,409,351
3,409,352
3,831,117
3,831,117
4,380,883
4,380,883
4,457,248
4,457,248
4,590,037
4,590,037
4,640,245
4,640,245
4,798,941
4,798,941
5,055,465
5,055,466
8,231,128
8,231,128
8,368,604
8,368,604
9,264,279
9,264,279
9,874,782
9,874,782
10,131,725
10,131,725
10,543,655
10,543,655
10,563,600
10,563,600
10,705,685
10,705,685
10,897,610
10,897,610
11,243,441
11,243,441
10,758,000
10,757,881
10,757,88110,758,00011,243,44111,243,44110,897,61010,897,61010,705,68510,705,68510,563,60010,563,60010,543,65510,543,65510,131,72510,131,7259,874,7829,874,7829,264,2799,264,2798,368,6048,368,6048,231,1288,231,1285,055,4665,055,4654,798,9414,798,9414,640,2454,640,2454,590,0374,590,0374,457,2484,457,2484,380,8834,380,8833,831,1173,831,1173,409,3523,409,3513,352,4313,352,4312,767,1522,767,1521,548,3271,548,3271,609,7611,609,7611,499,1381,416,4991,366,2231,246,2781,176,5891,173,0031,121,068
   > Total Current Liabilities 
385,381
409,902
403,026
425,103
470,855
499,826
563,340
602,117
602,117
557,197
557,196
914,127
914,126
974,380
974,382
1,009,158
1,009,158
952,951
952,951
1,058,442
1,058,442
1,143,176
1,143,176
1,234,902
1,234,903
1,284,815
1,284,815
1,386,210
1,386,212
1,392,200
1,392,201
1,721,275
1,721,275
1,929,522
1,929,521
1,925,161
1,925,160
2,614,239
2,614,238
2,662,605
2,662,605
2,450,539
2,450,539
2,271,565
2,271,563
2,962,241
2,962,241
3,495,873
3,217,949
3,385,850
3,385,852
3,152,000
3,151,119
3,151,1193,152,0003,385,8523,385,8503,217,9493,495,8732,962,2412,962,2412,271,5632,271,5652,450,5392,450,5392,662,6052,662,6052,614,2382,614,2391,925,1601,925,1611,929,5211,929,5221,721,2751,721,2751,392,2011,392,2001,386,2121,386,2101,284,8151,284,8151,234,9031,234,9021,143,1761,143,1761,058,4421,058,442952,951952,9511,009,1581,009,158974,382974,380914,126914,127557,196557,197602,117602,117563,340499,826470,855425,103403,026409,902385,381
       Short-term Debt 
53,650
30,463
25,702
24,273
37,443
30,610
59,541
135,475
98,141
78,290
59,306
93,354
108,976
56,811
77,854
41,832
71,530
76,369
95,183
83,744
107,094
150,436
183,015
214,851
254,706
296,267
352,940
336,148
394,498
428,101
412,948
412,683
700,604
481,472
784,751
512,748
809,323
992,123
1,313,755
975,966
1,316,673
703,067
1,040,838
520,602
851,265
948,164
1,338,870
1,387,018
1,783,259
1,038,811
1,450,357
1,129,000
1,129,766
1,129,7661,129,0001,450,3571,038,8111,783,2591,387,0181,338,870948,164851,265520,6021,040,838703,0671,316,673975,9661,313,755992,123809,323512,748784,751481,472700,604412,683412,948428,101394,498336,148352,940296,267254,706214,851183,015150,436107,09483,74495,18376,36971,53041,83277,85456,811108,97693,35459,30678,29098,141135,47559,54130,61037,44324,27325,70230,46353,650
       Accounts payable 
87,651
92,058
92,987
98,929
114,486
116,338
123,812
122,981
122,981
133,335
133,335
187,669
187,669
238,676
238,676
221,996
221,996
228,139
228,139
228,721
228,721
250,496
250,496
245,347
245,347
267,333
267,333
261,921
261,921
315,111
315,111
332,622
332,622
369,942
369,942
348,003
348,003
453,620
453,620
466,177
466,177
499,717
499,717
493,627
493,627
570,717
570,717
564,704
564,704
649,190
649,190
563,000
562,831
562,831563,000649,190649,190564,704564,704570,717570,717493,627493,627499,717499,717466,177466,177453,620453,620348,003348,003369,942369,942332,622332,622315,111315,111261,921261,921267,333267,333245,347245,347250,496250,496228,721228,721228,139228,139221,996221,996238,676238,676187,669187,669133,335133,335122,981122,981123,812116,338114,48698,92992,98792,05887,651
       Other Current Liabilities 
244,080
287,381
284,337
301,901
318,926
300,279
379,987
343,661
380,995
345,572
364,555
633,104
617,481
678,893
657,852
745,330
715,632
648,443
629,629
745,977
722,627
742,244
709,665
774,704
734,850
721,215
664,542
788,141
729,793
648,988
664,142
975,970
687,954
1,078,108
702,532
1,064,410
703,103
1,168,496
785,124
1,220,462
820,629
1,247,755
845,440
1,257,336
866,838
1,443,360
982,533
1,544,151
780,953
1,697,849
1,180,932
1,460,000
1,357,139
1,357,1391,460,0001,180,9321,697,849780,9531,544,151982,5331,443,360866,8381,257,336845,4401,247,755820,6291,220,462785,1241,168,496703,1031,064,410702,5321,078,108687,954975,970664,142648,988729,793788,141664,542721,215734,850774,704709,665742,244722,627745,977629,629648,443715,632745,330657,852678,893617,481633,104364,555345,572380,995343,661379,987300,279318,926301,901284,337287,381244,080
   > Long-term Liabilities 
735,687
763,101
773,563
821,175
895,368
916,673
935,798
1,007,644
1,007,644
991,130
991,131
1,853,025
1,853,026
2,378,051
2,378,049
2,400,193
2,400,194
2,878,166
2,878,166
3,322,441
3,322,441
3,314,072
3,314,072
3,355,135
3,355,134
3,355,430
3,355,430
3,412,731
3,412,729
3,663,265
3,663,265
6,509,853
6,509,853
6,439,082
6,439,083
7,339,118
7,339,119
7,260,543
7,260,544
7,469,120
7,469,120
8,093,116
8,093,116
8,292,035
8,292,037
7,743,444
7,743,444
7,401,737
7,679,661
7,857,591
7,857,589
7,606,000
7,606,762
7,606,7627,606,0007,857,5897,857,5917,679,6617,401,7377,743,4447,743,4448,292,0378,292,0358,093,1168,093,1167,469,1207,469,1207,260,5447,260,5437,339,1197,339,1186,439,0836,439,0826,509,8536,509,8533,663,2653,663,2653,412,7293,412,7313,355,4303,355,4303,355,1343,355,1353,314,0723,314,0723,322,4413,322,4412,878,1662,878,1662,400,1942,400,1932,378,0492,378,0511,853,0261,853,025991,131991,1301,007,6441,007,644935,798916,673895,368821,175773,563763,101735,687
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,391,210
0
6,930,771
0
6,552,047
0
0
0
0
00006,552,04706,930,77107,391,21000000000000000000000000000000000000000000000
> Total Stockholder Equity
689,256
671,743
701,395
692,613
702,754
689,551
712,232
717,690
717,690
745,903
745,903
1,867,989
1,867,989
1,904,082
1,904,082
1,894,880
1,894,879
1,922,727
1,922,727
1,899,445
1,899,445
2,023,015
2,023,015
2,085,848
2,085,848
2,462,405
2,462,405
2,468,604
2,468,604
2,556,186
2,556,185
2,478,049
2,478,049
2,558,187
2,558,187
2,593,732
2,593,732
3,156,980
3,156,980
3,421,549
3,421,549
3,493,287
3,493,287
3,481,671
3,481,671
3,539,222
3,539,222
3,496,074
3,496,074
3,583,754
3,583,754
3,487,000
3,486,992
3,486,9923,487,0003,583,7543,583,7543,496,0743,496,0743,539,2223,539,2223,481,6713,481,6713,493,2873,493,2873,421,5493,421,5493,156,9803,156,9802,593,7322,593,7322,558,1872,558,1872,478,0492,478,0492,556,1852,556,1862,468,6042,468,6042,462,4052,462,4052,085,8482,085,8482,023,0152,023,0151,899,4451,899,4451,922,7271,922,7271,894,8791,894,8801,904,0821,904,0821,867,9891,867,989745,903745,903717,690717,690712,232689,551702,754692,613701,395671,743689,256
   Common Stock
156,863
156,863
161,001
161,001
163,594
163,594
170,204
170,204
170,204
174,198
174,198
391,944
391,944
395,188
395,188
395,198
395,198
397,328
397,328
397,343
397,343
400,890
400,890
401,022
401,022
404,912
404,912
404,918
404,918
409,882
409,882
409,928
409,928
413,641
413,641
413,655
413,655
525,191
525,191
525,281
525,281
527,968
527,968
528,093
528,093
532,526
532,526
532,526
532,526
534,143
534,143
1,000
1,424
1,4241,000534,143534,143532,526532,526532,526532,526528,093528,093527,968527,968525,281525,281525,191525,191413,655413,655413,641413,641409,928409,928409,882409,882404,918404,918404,912404,912401,022401,022400,890400,890397,343397,343397,328397,328395,198395,198395,188395,188391,944391,944174,198174,198170,204170,204170,204163,594163,594161,001161,001156,863156,863
   Retained Earnings Total Equity00000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
262,537
262,537
278,286
278,286
576,946
576,946
591,961
591,961
582,725
582,725
598,242
598,242
574,909
574,909
780,606
780,606
843,308
843,308
1,197,454
1,197,454
1,203,647
1,203,647
1,264,539
1,264,539
1,186,356
1,291,693
1,242,043
1,316,144
1,277,574
1,316,158
1,449,011
1,707,969
1,713,490
1,708,059
1,769,066
1,724,221
1,757,325
1,724,346
1,801,041
1,738,181
1,757,893
1,738,181
1,843,361
1,843,361
2,190,000
2,189,672
2,189,6722,190,0001,843,3611,843,3611,738,1811,757,8931,738,1811,801,0411,724,3461,757,3251,724,2211,769,0661,708,0591,713,4901,707,9691,449,0111,316,1581,277,5741,316,1441,242,0431,291,6931,186,3561,264,5391,264,5391,203,6471,203,6471,197,4541,197,454843,308843,308780,606780,606574,909574,909598,242598,242582,725582,725591,961591,961576,946576,946278,286278,286262,537262,5370000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,196,253
0
1,205,655
0
1,205,655
0
0
0
0
00001,205,65501,205,65501,196,25300000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
532,393
514,880
540,394
531,612
539,160
525,957
542,028
284,949
284,949
293,419
293,419
899,099
899,099
916,933
916,933
916,957
916,956
927,157
927,157
927,193
927,193
841,519
841,519
841,518
841,518
860,039
860,039
860,039
860,039
881,765
881,764
881,765
776,428
902,503
828,402
902,503
863,919
1,182,778
923,820
1,182,778
1,188,209
1,196,253
1,241,098
1,196,253
1,229,232
1,205,655
1,268,515
1,205,655
253,816
1,206,250
1,206,250
1,296,000
-170,936
-170,9361,296,0001,206,2501,206,250253,8161,205,6551,268,5151,205,6551,229,2321,196,2531,241,0981,196,2531,188,2091,182,778923,8201,182,778863,919902,503828,402902,503776,428881,765881,764881,765860,039860,039860,039860,039841,518841,518841,519841,519927,193927,193927,157927,157916,956916,957916,933916,933899,099899,099293,419293,419284,949284,949542,028525,957539,160531,612540,394514,880532,393



6.4. Balance Sheets

All numbers in thousands.




6.5. Cash Flows

All numbers in thousands.




6.6. Income Statements

All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue5,047,500
Cost of Revenue-4,613,800
Gross Profit433,700433,700
 
Operating Income (+$)
Gross Profit433,700
Operating Expense-105,600
Operating Income328,100328,100
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense105,6000
 
Net Interest Income (+$)
Interest Income0
Interest Expense-239,300
Other Finance Cost-239,300
Net Interest Income0
 
Pretax Income (+$)
Operating Income328,100
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-76,200732,400
EBIT - interestExpense = 57,545
-107,900
134,000
Interest Expense239,300
Earnings Before Interest and Taxes (EBIT)296,845163,100
Earnings Before Interest and Taxes (EBITDA)990,000
 
After tax Income (+$)
Income Before Tax-76,200
Tax Provision-0
Net Income From Continuing Ops0-76,200
Net Income-105,300
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses4,719,400
Total Other Income/Expenses Net-404,3000
 

Technical Analysis of Clariane
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Clariane. The general trend of Clariane is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Clariane's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Clariane SE.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.278 < 2.294 < 2.37.

The bearish price targets are: 1.866 > 1.5141872376155 > 1.491.

Tweet this
Clariane SE Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Clariane SE. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Clariane SE Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Clariane SE. The current macd is 0.0518116.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Clariane price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Clariane. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Clariane price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Clariane SE Daily Moving Average Convergence/Divergence (MACD) ChartClariane SE Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Clariane SE. The current adx is 29.09.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Clariane shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Clariane SE Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Clariane SE. The current sar is 2.25178074.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Clariane SE Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Clariane SE. The current rsi is 50.41. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Clariane SE Daily Relative Strength Index (RSI) ChartClariane SE Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Clariane SE. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Clariane price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Clariane SE Daily Stochastic Oscillator ChartClariane SE Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Clariane SE. The current cci is -2.91962351.

Clariane SE Daily Commodity Channel Index (CCI) ChartClariane SE Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Clariane SE. The current cmo is -7.64950757.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Clariane SE Daily Chande Momentum Oscillator (CMO) ChartClariane SE Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Clariane SE. The current willr is -89.63963964.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Clariane SE Daily Williams %R ChartClariane SE Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Clariane SE.

Clariane SE Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Clariane SE. The current atr is 0.10060712.

Clariane SE Daily Average True Range (ATR) ChartClariane SE Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Clariane SE. The current obv is -14,493,204.

Clariane SE Daily On-Balance Volume (OBV) ChartClariane SE Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Clariane SE. The current mfi is 51.46.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Clariane SE Daily Money Flow Index (MFI) ChartClariane SE Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Clariane SE.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-07-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-08-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Clariane SE Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Clariane SE based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.407
Ma 20Greater thanMa 501.928
Ma 50Greater thanMa 1001.784
Ma 100Greater thanMa 2001.824
OpenGreater thanClose1.920
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Clariane with someone you think should read this too:
  • Are you bullish or bearish on Clariane? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Clariane? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Clariane SE

I send you an email if I find something interesting about Clariane SE.


Comments

How you think about this?

Leave a comment

Stay informed about Clariane SE.

Receive notifications about Clariane SE in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.